GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » NanoRepro AG (XTER:NN6) » Definitions » EV-to-FCF

NanoRepro AG (XTER:NN6) EV-to-FCF : -1.51 (As of Dec. 12, 2024)


View and export this data going back to 2008. Start your Free Trial

What is NanoRepro AG EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, NanoRepro AG's Enterprise Value is €-14.30 Mil. NanoRepro AG's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2024 was €9.49 Mil. Therefore, NanoRepro AG's EV-to-FCF for today is -1.51.

The historical rank and industry rank for NanoRepro AG's EV-to-FCF or its related term are showing as below:

XTER:NN6' s EV-to-FCF Range Over the Past 10 Years
Min: -144.44   Med: -5.68   Max: 7.34
Current: -1.51

During the past 13 years, the highest EV-to-FCF of NanoRepro AG was 7.34. The lowest was -144.44. And the median was -5.68.

XTER:NN6's EV-to-FCF is ranked better than
98.97% of 97 companies
in the Medical Diagnostics & Research industry
Industry Median: 27.56 vs XTER:NN6: -1.51

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2024-12-12), NanoRepro AG's stock price is €1.345. NanoRepro AG's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was €-0.252. Therefore, NanoRepro AG's PE Ratio (TTM) for today is At Loss.


NanoRepro AG EV-to-FCF Historical Data

The historical data trend for NanoRepro AG's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NanoRepro AG EV-to-FCF Chart

NanoRepro AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only -8.97 -31.89 8.37 -0.29 -0.46

NanoRepro AG Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -0.29 - -0.46 -

Competitive Comparison of NanoRepro AG's EV-to-FCF

For the Diagnostics & Research subindustry, NanoRepro AG's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NanoRepro AG's EV-to-FCF Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, NanoRepro AG's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where NanoRepro AG's EV-to-FCF falls into.



NanoRepro AG EV-to-FCF Calculation

NanoRepro AG's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=-14.295/9.492
=-1.51

NanoRepro AG's current Enterprise Value is €-14.30 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. NanoRepro AG's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2024 was €9.49 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


NanoRepro AG  (XTER:NN6) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

NanoRepro AG's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=1.345/-0.252
=At Loss

NanoRepro AG's share price for today is €1.345.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. NanoRepro AG's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was €-0.252.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


NanoRepro AG EV-to-FCF Related Terms

Thank you for viewing the detailed overview of NanoRepro AG's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


NanoRepro AG Business Description

Traded in Other Exchanges
Address
Untergasse 8, Marburg, DEU, 35037
NanoRepro AG is engaged in the development, manufacturing, and distribution of CE-certified rapid diagnostic tests (self-tests) and food supplements for both, home and professional use.
Executives
Dr. Olaf Stiller Supervisory Board
Andre Schulte-südhoff Supervisory Board
Lisa Jüngst Board of Directors
Michael Tillmann Supervisory Board

NanoRepro AG Headlines

No Headlines